Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : ajtj's Post-Lobotomy Market Charts and Thoughts -- Ignore unavailable to you. Want to Upgrade?

To: Qone0 who wrote (83138)	12/8/2023 10:28:02 AM
From: Sun Tzu	Read Replies (1) \| Respond to of 96981

In this case the market expectation is that they will get approved. Morgan Stanley just upgraded BLUE, which is why it is up today. Usually I don't care what most analysts say, but the upgrading a bio so close to the FDA decision is risky for an analyst's career. So he has skin in the game. While we're on the topic, BLUE filed for a 125 mil shelf offering. This is in anticipation of getting the approval. So if they get it, they will sell shares so they can manufacture and market it. That may or may not drag the stock down.